pamidronate has been researched along with Cancer of Parathyroid in 17 studies
Excerpt | Relevance | Reference |
---|---|---|
"Parathyroid carcinoma is rare and the associated hypercalcaemia is often resistant to all treatment." | 5.29 | Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate. ( Braatvedt, GD; Corrall, RJ; Newrick, PG; Sheffield, E; Webb, AJ, 1994) |
"Primary hyperparathyroidism is characterised by high parathyroid hormone (PTH) levels and concomitant hypercalcaemia." | 1.40 | Exceptional localisation of an ectopic parathyroid adenoma at the level of the hyoid bone. ( Musters, L; Smit, C; van Ginhoven, TM, 2014) |
"We report on a patient with parathyroid carcinoma with hypercalcaemia and pulmonary metastases, treated with pamidronate and radiotherapy and later with surgery." | 1.31 | Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma. ( Boquist, L; Kristoffersson, A; Rasmuson, T, 2000) |
"Parathyroid carcinoma is rare and the associated hypercalcaemia is often resistant to all treatment." | 1.29 | Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate. ( Braatvedt, GD; Corrall, RJ; Newrick, PG; Sheffield, E; Webb, AJ, 1994) |
"Primary hyperparathyroidism is usually associated with normal or elevated serum 1,25-dihydroxyvitamin D [1,25(OH)2D] levels." | 1.29 | Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease. ( Brossard, JH; D'Amour, P; Garon, J; Gascon-Barré, M; Lepage, R, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.88) | 18.7374 |
1990's | 9 (52.94) | 18.2507 |
2000's | 3 (17.65) | 29.6817 |
2010's | 4 (23.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basok, AB | 1 |
Rogachev, B | 1 |
Haviv, YS | 1 |
Vorobiov, M | 1 |
Musters, L | 1 |
van Ginhoven, TM | 1 |
Smit, C | 1 |
Pittaway, JF | 1 |
Srirangalingam, U | 1 |
Hanson, PL | 1 |
Jones, P | 1 |
Drake, WM | 1 |
Patnaik, S | 1 |
Lai, YK | 1 |
Manouras, A | 1 |
Toutouzas, KG | 1 |
Markogiannakis, H | 1 |
Lagoudianakis, E | 1 |
Papadima, A | 1 |
Antonakis, PT | 1 |
Kafiri, G | 1 |
Bramis, I | 1 |
Gurevich, Y | 1 |
Poretsky, L | 1 |
de Papp, AE | 1 |
Kinder, B | 1 |
LiVolsi, V | 1 |
Gupta, SM | 1 |
Stewart, AF | 1 |
Newrick, PG | 1 |
Braatvedt, GD | 1 |
Webb, AJ | 1 |
Sheffield, E | 1 |
Corrall, RJ | 1 |
Mundy, GR | 1 |
Ishimura, E | 2 |
Miki, T | 2 |
Koyama, H | 1 |
Harada, K | 2 |
Nakatsuka, K | 2 |
Inaba, M | 1 |
Nishizawa, Y | 2 |
Morii, H | 2 |
Brossard, JH | 1 |
Garon, J | 1 |
Lepage, R | 1 |
Gascon-Barré, M | 1 |
D'Amour, P | 1 |
Vainas, IG | 1 |
Tsilikas, C | 1 |
Grecu, A | 1 |
Pasaitu, K | 1 |
Stergiou, I | 1 |
Kortsaris, AH | 1 |
Sims, EC | 1 |
Rogers, PB | 1 |
Besser, GM | 1 |
Plowman, PN | 1 |
Rasmuson, T | 1 |
Kristoffersson, A | 1 |
Boquist, L | 1 |
Hiratani, K | 1 |
Vega, EM | 1 |
Mautalen, CA | 1 |
Mann, K | 1 |
1 review available for pamidronate and Cancer of Parathyroid
Article | Year |
---|---|
Metastatic parathyroid carcinoma (mPCa): natural history and treatment of a case.
Topics: Antineoplastic Agents; Calcitonin; Carcinoma; Diagnosis, Differential; Diphosphonates; Humans; Lung | 1997 |
16 other studies available for pamidronate and Cancer of Parathyroid
Article | Year |
---|---|
Treatment of extreme hypercalcaemia: the role of haemodialysis.
Topics: Adenoma; Aged; Bone Density Conservation Agents; Calcitonin; Dexamethasone; Diphosphonates; Fluid Th | 2018 |
Exceptional localisation of an ectopic parathyroid adenoma at the level of the hyoid bone.
Topics: Adenoma; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Hyoid Bone; Hypercalcemia | 2014 |
Renal replacement therapy as a treatment for severe refractory hypercalcemia.
Topics: Adenoma; Adult; Carcinoma; Cinacalcet; Diphosphonates; Drug Resistance; Emergencies; Female; Furosem | 2014 |
Just hypercalcaemia or acute ST elevation myocardial infarction? A review of hypercalcaemia-related electrocardiographic changes.
Topics: Aged; Bone Density Conservation Agents; Calcitonin; Calcium; Diphosphonates; Disease Management; Ele | 2015 |
Intracystic hemorrhage in a mediastinal cystic adenoma causing parathyrotoxic crisis.
Topics: Adenoma; Adult; Bone Density Conservation Agents; Cystadenoma; Diphosphonates; Diuretics; Fluid Ther | 2008 |
Possible prevention of hungry bone syndrome following parathyroidectomy by preoperative use of pamidronate.
Topics: Adenoma; Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Hypocalcemia; Pamid | 2008 |
Parathyroid carcinoma arising from parathyroid hyperplasia: autoinfarction following intravenous treatment with pamidronate.
Topics: Adult; Cell Transformation, Neoplastic; Diphosphonates; Humans; Hyperplasia; Infarction; Injections, | 1994 |
Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.
Topics: Calcium; Carcinoma; Diphosphonates; Female; Humans; Hypercalcemia; Middle Aged; Pamidronate; Parathy | 1994 |
Evaluation and treatment of hypercalcemia.
Topics: Adenoma; Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Diphosphonates; Fe | 1994 |
Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma.
Topics: Adenoma; Adult; Alkaline Phosphatase; Bone and Bones; Calcitriol; Calcium; Creatinine; Diphosphonate | 1993 |
Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
Topics: Adenoma; Alkaline Phosphatase; Bone Resorption; Calcitonin; Calcitriol; Calcium; Calcium Carbonate; | 1993 |
Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
Topics: Adenocarcinoma; Adenoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols | 1998 |
Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma.
Topics: Antineoplastic Agents; Calcium; Combined Modality Therapy; Diphosphonates; Female; Follow-Up Studies | 2000 |
Regulation of parathyroid hormone secretion by calcium in patients with parathyroid adenoma.
Topics: Adenoma; Adult; Calcium; Diphosphonates; Female; Humans; Male; Pamidronate; Parathyroid Hormone; Par | 1992 |
Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma.
Topics: Adult; Diphosphonates; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Middle Aged; Pam | 1991 |
Oral biphosphonate therapy in metastatic parathyroid carcinoma.
Topics: Diphosphonates; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Pamidronate | 1985 |